SCHEMBL3030760

SCHEMBL3030760

C=CCC1(C(F)(F)F)OC(=O)Nc2ccc(Cl)cc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELOVL6 Q9H5J4 14/20 0.59
CYP46A1 Q9Y6A2 3/20 0.53
PGR P06401 3/20 0.51
NR1I2 O75469 1/20 0.51
NR3C1 P04150 1/20 0.51
ADRB1 P08588 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
MAPT P10636 1/20 0.51
CNR1 P21554 1/20 0.51
SLC6A2 P23975 1/20 0.51
HTR2A P28223 1/20 0.51
HTR2C P28335 1/20 0.51
MAPK1 P28482 1/20 0.51
AGTR1 P30556 1/20 0.51
CCKBR P32239 1/20 0.51
PPARG P37231 1/20 0.51
OPRK1 P41145 1/20 0.51
SLC6A3 Q01959 1/20 0.51
PDE4D Q08499 1/20 0.51
PDE3A Q14432 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8087172 0.88 ELOVL6 (0.54) ELOVL6CYP46A1PGRNR1I2NR3C1
SCHEMBL3037679 0.83 ELOVL6 (0.62) ELOVL6CYP46A1PGRNR1I2NR3C1
Hydrochloric Acid SCHEMBL3033669 0.82 ELOVL6 (0.58) ELOVL6CYP46A1PGRNR1I2NR3C1
SCHEMBL3034041 0.81 ELOVL6 (0.60) ELOVL6CYP46A1PGRNR1I2NR3C1
SCHEMBL3036325 0.81 ELOVL6 (0.58) ELOVL6CYP46A1PGRNR1I2NR3C1
SCHEMBL3044483 0.79 ELOVL6 (0.60) ELOVL6CYP46A1PGRNR1I2NR3C1
SCHEMBL17273553 0.79 CYP46A1 (0.58) ELOVL6CYP46A1PGRNR1I2NR3C1
SCHEMBL3041683 0.79 ELOVL6 (0.58) ELOVL6CYP46A1PGRNR1I2NR3C1
SCHEMBL7704788 0.79 CYP46A1 (0.60) ELOVL6CYP46A1PGRNR1I2NR3C1
SCHEMBL13908047 0.78 ELOVL6 (0.60) ELOVL6CYP46A1PGRNR1I2NR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2210880-B1 Benzoxazinone derivatives MSD KK (JP) 2015-08-26 EP disclosed
US-8314094-B2 Benzoxazinone derivative MSD K.K (JP) 2012-11-20 US disclosed
US-20100210636-A1 BENZOXAZINONE DERIVATIVE BANYU PHARMACEUTICAL CO., LTD. 2010-08-19 US disclosed
EP-2210880-A1 BENZOXAZINONE DERIVATIVE Banyu Pharmaceutical Co., Ltd. (JP) 2010-07-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210636-A1 BENZOXAZINONE DERIVATIVE HAX1, CYP4X1, CYP19A1 ELOVL6 3630/4885CYP46A1 114/4885PGR 546/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.